亚洲视频一区二区三区四区-亚洲视频一区二区三区-亚洲视频一区二区-亚洲视频一区-亚洲视频一二三-亚洲视频一二区

咨詢熱線

15000266580

當(dāng)前位置:首頁(yè)  >  技術(shù)文章  >  日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

更新時(shí)間:2013-07-26      點(diǎn)擊次數(shù):3088

   日本研究人員獲得批準(zhǔn),可以開展利用干細(xì)胞療法治療老年性黃斑變性(age-related macular degeneration,AMD),一種引起老年人視力下降的主要疾病。日本的研究人員誘導(dǎo)AMD患者身上取下的皮膚細(xì)胞使其處于一種類似于干細(xì)胞的狀態(tài)后再將其轉(zhuǎn)至患者,以達(dá)到治療效果。

干細(xì)胞具有廣泛的性,具有廣泛的醫(yī)療前景。去年,Kyoto University的Shinya Yamanaka即憑借干細(xì)胞領(lǐng)域的研究獲得諾貝爾獎(jiǎng)。

詳細(xì)英文報(bào)道:

Japanese researchers have won permission to embark on a pioneering clinical study of a stem cell therapy for age-related macular degeneration, a major cause of vision loss in aging patients. The planned trial is being hailed as the first human test of a stem cell therapy made from patients' own cells.

Japan provides an appropriate proving ground for induced pluripotent stem (iPS) cell therapies. Last year professor Shinya Yamanaka of Kyoto University won a piece of a Nobel Prize for his work on converting adult cells into stem cells. The stem cells have broad potential in medicine because they can evolve into a variety to cell types with the potential to repair diseased or damaged organs, and they skirt the political quagmire of harvesting stem cells from human embryos.

As AFP reported, researchers in the Japanese study plan to take skin cells from AMD patients, coax the cells into a stem-like state, and then reintroduce them to the patients. The study calls for testing the therapeutic approach in 6 patients, with the trial set to begin next year in Kobe. Applications to conduct the trial came from the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation.

Stem cells offer a whole new way to treat vision problems. Today, AMD patients take injected therapies such as Eylea and Lucentis to combat the disease by inhibiting VEGF to stymie the formation of leaky blood vessels, which lead to deterioration of the eye tissue that is key to central vision.

However, with pioneering clinical trials comes great risk. As professor Chris Mason of University College London noted to the BBC, researchers lack evidence on the safety of iPS cells in humans. The hope is that using patients' own cells to generate the therapies could reduce the risk of their bodies rejecting the stem cells.

 

聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號(hào)7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2024 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號(hào):滬ICP備10013034號(hào)-2     sitemap.xml
技術(shù)支持:化工儀器網(wǎng)    管理登陸
主站蜘蛛池模板: 国产成人亚洲综合a∨婷婷 国产成人亚洲精品乱码在线观看 | 色戒西瓜 | 特级www| 1717she精品视频在线观看 | 美女大乳被捏羞羞漫画 | 很黄的网站在线观看 | 东北恋哥在线播放免费播放 | www.5151淫| 国内精品视频一区二区三区八戒 | 成人免费观看在线视频 | 国产精品久久久久久福利 | 色婷婷综合久久久 | 特黄特a级特别特级特毛片 特黄a级三级三级野战 | 免费超级乱淫播放手机版 | 美女班主任让我爽了一夜视频 | 国产一卡二卡3卡4卡更新 | 男人和女人上床 | 欧美日韩亚洲另类人人澡 | 9966国产精品视频 | 久久www免费人成_看片高清 | 91国内精品久久久久影院优播 | porno movie hd高清| 黄情视频 | 暖暖的韩国免费观看 | 91精品国产品国语在线不卡 | 欧美在线视频一区 | piss美女厕所小便 | 超爽人人做人人爽 | 欧美日韩国产在线人成dvd | 特黄特色大片免费高清视频 | 天天爱天天做天天爽天天躁 | 好男人在线观看hd中字 | 蘑菇香蕉茄子绿巨人丝瓜草莓 | 五月天精品视频播放在线观看 | 国产亚洲一级精品久久 | 日本捏胸吃奶视频免费 | 女人和拘做受全过程免费 | 特黄特黄一级高清免费大片 | 91欧洲在线视精品在亚洲 | 91精品国产91久久久久久麻豆 | 春意午夜影院 |